These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17637209)

  • 1. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
    Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G
    Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].
    Vercueil L
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():14-22. PubMed ID: 10916032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic criteria for Parkinson syndromes, expecting Parkinson's disease].
    Vidailhet M
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():43-50. PubMed ID: 10916036
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differential diagnosis of Parkinson's syndromes--an overview].
    Dohm CP; Pilgram SM; Liman J; Bähr M; Mohr A; Kermer P
    Dtsch Med Wochenschr; 2009 Apr; 134(17):892-6. PubMed ID: 19370503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging and spectroscopy in Parkinson's disease.
    Martin WR
    Adv Neurol; 2001; 86():197-203. PubMed ID: 11553978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism.
    Hotter A; Esterhammer R; Schocke MF; Seppi K
    Mov Disord; 2009; 24 Suppl 2():S711-20. PubMed ID: 19877241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments of brain imaging for Parkinson's disease and related disorders.
    Piccini P; Brooks DJ
    Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria for Parkinson's disease.
    Albanese A
    Neurol Sci; 2003 May; 24 Suppl 1():S23-6. PubMed ID: 12774207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic criteria and differential diagnosis of Parkinson disease].
    Takáts A
    Ideggyogy Sz; 2003 May; 56(5-6):144-54. PubMed ID: 12861955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease.
    Mahlknecht P; Hotter A; Hussl A; Esterhammer R; Schocke M; Seppi K
    Neurodegener Dis; 2010; 7(5):300-18. PubMed ID: 20616565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
    Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
    Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of magnetic resonance spectroscopic imaging in patients with Parkinson's disease].
    Naruse S; Kizu O; Furuya S
    Nihon Rinsho; 1997 Jan; 55(1):262-4. PubMed ID: 9014461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
    Henchcliffe C; Shungu DC; Mao X; Huang C; Nirenberg MJ; Jenkins BG; Beal MF
    Ann N Y Acad Sci; 2008 Dec; 1147():206-20. PubMed ID: 19076443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
    Seppi K
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S400-5. PubMed ID: 18267272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the rates of the tricarboxylic acid (TCA) cycle and glutamine synthesis in the monkey brain with hemiparkinsonism induced by intracarotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): studies by non-invasive 13C-magnetic resonance spectroscopy.
    Kanamatsu T; Otsuki T; Tokuno H; Nambu A; Takada M; Okamoto K; Watanabe H; Umeda M; Tsukada Y
    Brain Res; 2007 Nov; 1181():142-8. PubMed ID: 17919469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating Parkinson's disease from other parkinsonian disorders.
    Alvarez MV; Evidente VG; Driver-Dunckley ED
    Semin Neurol; 2007 Sep; 27(4):356-62. PubMed ID: 17701873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
    Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
    NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.